Ascendiant Capital Maintains Buy on Aemetis, Lowers Price Target to $20
Aemetis: Real Progress, But The Balance Sheet Is Still A Risk
Aemetis, Inc. (AMTX) Q2 2026 Earnings Call Transcript
Aemetis Q2 EPS $(0.13) Beats $(0.28) Estimate, Sales $62.700M Miss $69.498M Estimate
Aemetis' Universal Biofuels Subsidiary Secures ~$17M Order To Provide Over 18M Liters Of Biodiesel To India's Three Federal Oil Marketing Firms
Aemetis’ Ethanol And Renewable Natural Gas Subsidiaries Receives Funds From Sales Of $18M Of Section 45Z Clean Fuel Production Tax Credits
Aemetis Does Not Benefit From The Iran War And Remains Highly Risky
Ascendiant Capital Maintains Buy on Aemetis, Raises Price Target to $22
CPCFA Adopts Initial Resolution Supporting up to $1.1 Billion of Tax-Exempt Financing for Aemetis Projects
Stonegate Capital Partners Updates Coverage On Aemetis, Inc. (AMTX) 1Q26
Aemetis Inc (AMTX): Revenue Jumps and Indian Subsidiary IPO on Track
Aemetis Q1 Earnings Call Highlights
Aemetis (AMTX) Q1 2026 Earnings Transcript
Aemetis, Inc. (AMTX) Q1 2026 Earnings Call Transcript
Aemetis (AMTX) Reports Q1 Loss, Misses Revenue Estimates
Aemetis (NASDAQ:AMTX) Falls 4% Premarket After Q1 Miss on Revenue and Earnings
Aemetis Reports First Quarter 2026 Financial Results
Aemetis Q1 EPS $(0.33) Misses $(0.27) Estimate, Sales $54.619M Miss $67.268M Estimate
Aemetis to Review First Quarter 2026 Financial Results on May 7, 2026
Ascendiant Capital Maintains Buy on Aemetis, Raises Price Target to $21
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.